New drug tested for millions suffering from stubborn sinus condition

This study tested whether the drug dupilumab could help adults with a specific type of chronic sinusitis that does not involve nasal polyps. Thirty-three participants were randomly assigned to receive either dupilumab or a placebo for six months to see if it improved their sinus symptoms and quality of life. The goal was to see if this medication, already used for other conditions, could offer a new treatment option for this common and difficult-to-manage form of sinus disease.